Jump to content


Hang onto your hat: Sclero Forums Upgrade May 14-21, 2017!! The Forums will be offline for up to 4 days, and then will return with an entirely new look and feel.


Photo

Potential Scleroderma Gene Therapy Moving into Preclinical Dosing Study, Fibrocell Reports.

linear ssc treatments

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,901 posts
  • Location:West Sussex

Posted 10 February 2016 - 06:08 AM

Potential Scleroderma Gene Therapy Moving into Preclinical Dosing Study, Fibrocell Reports.

 

Fibrocell has finished a proof-of-concept trial on FCX-013 for the treatment of linear scleroderma. The trial examined the efficacy of FCX-013 in reducing dermal thickness in fibrotic tissue. Scleroderma News Today, 02/09/2016. (Also see: Linear Scleroderma Treatments)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster
SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager
ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)